Hypersensitivity (including to tetanus toxoid), acute infectious diseases, fever.
Local reactions: rapid soreness, erythema, and tightness at the injection site. General reactions (rarely) - increased body temperature, irritability, moodiness, drowsiness.
Prevention of infections caused by Haemophilus influenzae type b (meningitis, septicemia, pneumonia, epiglottitis, etc.), in children aged 2 months to 5 years.
The conjugation of PRP with the carrier protein gives the polysaccharide the properties of a T-dependent antigen. In addition, repeated injections have a pronounced booster effect, which is a confirmation of the formation of immunological memory as a result of primary vaccination.
At a temperature of 2-8 °C (in the refrigerator). (do not freeze).
Keep out of reach of children.
Shelf life of the drug AKT-HIB® (vaccine for the prevention of infection caused by Haemophilus influenzae type b, conjugate)lyophilizate for the preparation of a solution for intramuscular and subcutaneous administration — 3 years.
lyophilizate for the preparation of a solution for intramuscular and subcutaneous administration 10 mcg/0.5 ml 10 mcg/0.5-3 years. 5 years old solvent
Do not use after the expiration date indicated on the package.
1 dose (0.5 ml) of the vaccine after dissolving the lyophilizate contains polysaccharide Haemophilus influenzae type b (Hib), conjugated with tetanus toxoid-10 mcg, hydroxymethyl aminomethane-0.6 mg, sucrose-42.5 mg. Lyophilized powder for injection in vials of 1 dose complete with solvent in syringes of 0.5 ml and 10 doses complete with solvent in vials of 5 and 10 ml, respectively, in a box of 1 (1 dose) and 10 (10 doses) pcs. The solvent contains sodium chloride 2 mg, water for injection q. s. up to 0.5 ml.
P/c or v / m. Children under 2 years of age are injected into the anterolateral area of the thigh, children over 2 years of age-in the area of the deltoid muscle. There are three possible vaccination schemes:
1) children aged 2 to 6 months — 3 injections of one dose (0.5 ml) at intervals of 1-2 months, revaccination — one dose (0.5 ml) 12 months after the third injection,
2) children aged 6 to 12 months — 2 injections of one dose (0.5 ml) at intervals of 1-2 months, revaccination — one dose (0.5 ml) 12 months after the second injection,
3) children aged 1 to 5 years — a single injection of one dose (0.5 ml).
Before use, dilute the contents of the bottle in the solvent contained in the attached syringe. The bottle must be shaken until the lyophilizate is completely dissolved.
J07AG01 Haemophilus influenzae B purified conjugated antigen
